DeepCurrents Investment Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

DeepCurrents Investment Group’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,822	Closed	-$372K	–	210
2025 Q1	$372K	Buy	+2,822	New	+$352K	0.01%	173

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

DeepCurrents Investment Group's ITCI Position: Q2 2025 in Review

DeepCurrents Investment Group sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 2,822 shares — an estimated $372K sold.

DeepCurrents Investment Group first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $372K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

DeepCurrents Investment Group reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
DeepCurrents Investment Group sold 2,822 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $372K.
DeepCurrents Investment Group first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
DeepCurrents Investment Group's Intra-Cellular Therapies Inc. position peaked at $372K in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on DeepCurrents Investment Group's 13F filing for Q2 2025, filed 14 Aug 2025.